Kevin Y Heo

Mr. Kevin Y Heo


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2024 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
KHKevin Y Heo
Kevin Y Heo
RGRahul K. Goel
Rahul K. Goel
AWAlyssa Woltemath
Alyssa Woltemath
AFAndrew Fuqua
Andrew Fuqua
BHBryce T. Hrudka
Bryce T. Hrudka
JWJacob M. Wilson
Jacob M. Wilson

11 January 2024 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
KBKyle E. Bundschuh
Kyle E. Bundschuh
BMBrian T. Muffly
Brian T. Muffly
AAAyomide M. Ayeni
Ayomide M. Ayeni
KHKevin Y Heo
Kevin Y Heo
SKSameer R. Khawaja
Sameer R. Khawaja
GGGeorge N. Guild
George N. Guild

11 October 2024 in Arthroplasty Today
Verified
Journal Article
Open access
KHKevin Y Heo
Kevin Y Heo
RGRahul K. Goel
Rahul K. Goel
AFAndrew Fuqua
Andrew Fuqua
JHJeffrey S. Holmes
Jeffrey S. Holmes
BMBrian T. Muffly
Brian T. Muffly
APAjay Premkumar
Ajay Premkumar
Glucagon-like peptide-1 (GLP-1) agonists have emerged as a powerful diabetic treatment adjunct; however, its effects on outcomes following total knee arthroplasty (TKA) are not well known. The purpose of this study was to compare the risk of complications after TKA in patients with type-2 diabetes who were on GLP-1 agonists with those who were not. In total, 34,696 type 2 diabetes patients undergoing primary TKA between 2016 and 2021 were retrospectively reviewed utilizing a large national database. Propensity score matching was employed to match patients on GLP-1 agonists to controls at a 1:1 ratio (n = 2388 each). Multivariable logistic regression was utilized to examine 90-day and 1-year TKA outcomes between cohorts. Controls had higher odds of extended hospital stays (≥3 days) (odds ratio 1.29, P < .001). However, surgical complication rates at 90-days including surgical site infection and prosthetic joint infection were not significantly different. Similarly, no differences were seen in medical complications. There were also no significant differences in rates of all-cause revision TKA and aseptic revision TKA at 1 year postoperatively. This study found that GLP-1 agonist use was not associated with increased medical or surgical complication rates in patients with diabetes undergoing TKA and was associated with lower rates of extended hospital stays after surgery. Given the potential for increased glycemic control and weight loss in patients using GLP-1 agonists, more data are needed to delineate the potential role of GLP-1 agonists in preoperative optimization of patients with diabetes prior to joint arthroplasty to minimize postoperative complications.

24 January 2024 in HAND
Verified
Journal Article
Closed access
AKAnthony L. Karzon
Anthony L. Karzon
ENEhab M. Nazzal
Ehab M. Nazzal
HCHayden L. Cooke
Hayden L. Cooke
KHKevin Y Heo
Kevin Y Heo
OOOnyinye Okonma
Onyinye Okonma
EWEric R. Wagner
Eric R. Wagner
Background: Upper extremity (UE) fractures are a common reason for emergency department (ED) visits, but recent data on their epidemiology are lacking. This study aimed to describe the incidence, demographics, patient characteristics, and associated health care factors of UE fractures, hypothesizing that they would remain prevalent in the ED setting. Methods: Using the Nationwide ED Sample database, patients presenting to the ED with UE fractures in 2016 were identified, and population estimates were used to calculate incidence rates. Data on insurance status, trauma designation, cost, and teaching status were analyzed. Results: The study identified 2 118 568 patients with UE fractures, representing 1.5% of all ED visits in 2016. Men accounted for 54.2% of UE fractures, with phalangeal fractures being most common. Distal radius and/or ulna fractures were most common in women (30.4%). The greatest proportion of UE fractures (23.2%) occurred in patients aged 5 to 14 years (1195.5 per 100 000). Nontrauma centers were the most common treating institutions (50.4%), followed by level I (19.5%), II (15.3%), and III (12.8%) centers. The greatest proportion of fractures (38.3%) occurred in the southern United States. Emergency department cost of treatment was almost 2-fold in patients with open UE fractures compared with closed. Conclusion: This study provides important epidemiological information on UE fractures in 2016. The incidence rate of UE fractures in the ED has remained high, with most occurring in the distal radius, phalanges, and clavicle. In addition, UE fractures were most common in younger patients, men, and those in the southern United States during the summer. These findings can be useful for health care providers and policymakers when evaluating and treating patients with UE fractures.

21 August 2023 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
KHKevin Y Heo
Kevin Y Heo
AKAnthony Karzon
Anthony Karzon
JSJason Shah
Jason Shah
AAAyomide Ayeni
Ayomide Ayeni
BRBridger Rodoni
Bridger Rodoni
APAjay Premkumar
Ajay Premkumar

2 November 2023 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
BMBrian T. Muffly
Brian T. Muffly
AAAyomide M. Ayeni
Ayomide M. Ayeni
CJCorey A. Jones
Corey A. Jones
KHKevin Y Heo
Kevin Y Heo
GGGeorge N. Guild
George N. Guild
APAjay Premkumar
Ajay Premkumar